Comparison of stroke- and bleed-related healthcare resource utilization and costs among patients with newly diagnosed non-valvular atrial fibrillation and newly treated with dabigatran, rivaroxaban, or warfarin
Gilligan, Adrienne M., Franchino-Elder, Jessica, Song, Xue, Wang, Cheng, Henriques, Caroline, Sainski-Nguyen, Amy, Wilson, Kathleen, Smith, David M., Sander, StephenLanguage:
english
Journal:
Expert Review of Pharmacoeconomics & Outcomes Research
DOI:
10.1080/14737167.2019.1527220
Date:
September, 2018
File:
PDF, 1.45 MB
english, 2018